Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study

Atrial fibrillation as a precursor of mRNA-1273 SARS-CoV-2 vaccine-induced pericarditis

(2022) Frank X. Scheuermeyer et al.   Canadian Journal of Emergency Medicine

Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis

(2022) Xintong Li et al.   BMJ-British Medical Journal

Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England

(2022) William N. Whiteley et al.   PLOS MEDICINE

Myocarditis With COVID-19 mRNA Vaccines

(2021) Biykem Bozkurt et al.   CIRCULATION

Surveillance for Adverse Events After COVID-19 mRNA Vaccination

(2021) Nicola P. Klein et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Divergent vaccination policies could fuel mistrust and hesitancy

(2021) Rebecca Forman et al.   LANCET

Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study

(2021) Eric Yuk Fai Wan et al.   LANCET INFECTIOUS DISEASES

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland

(2021) C. R. Simpson et al.   NATURE MEDICINE

Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis

(2021) Sue Pavord et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study

(2021) Julia Hippisley-Cox et al.   BMJ-British Medical Journal

Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older

(2021) Marie Joelle Jabagi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cardiovascular and haematological events post COVID‐19 vaccination: A systematic review

(2021) Dana Al‐Ali et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

China’s COVID vaccines have been crucial — now immunity is waning

(2021) Smriti Mallapaty   NATURE

Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection

(2021) Martina Patone et al.   NATURE MEDICINE

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection

(2021) Martina Patone et al.   NATURE MEDICINE

Myocarditis after Covid-19 Vaccination in a Large Health Care Organization

(2021) Guy Witberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study

(2021) Anders Husby et al.   BMJ-British Medical Journal

PICK-ing Malaysia’s Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio

(2021) Jing Lian Suah et al.   Vaccines

Immunization stress-related responses: Implications for vaccination hesitancy and vaccination processes during the COVID-19 pandemic

(2021) Steven Taylor et al.   JOURNAL OF ANXIETY DISORDERS

Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview

(2021) Amir Abbas Shiravi et al.   Cardiology and Therapy

Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000–2015

(2018) Jiayao Lei et al.   VACCINE

Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines

(2018) Sonali Kochhar et al.   VACCINE

Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice

(2011) Y. G. WELDESELASSIE et al.   EPIDEMIOLOGY AND INFECTION

What Should an Ideal Vaccine Postlicensure Safety System Be?

(2009) Marie R. Griffin et al.   AMERICAN JOURNAL OF PUBLIC HEALTH